Abstract
We tested the hypothesis that six toxic risk factors from the TIGAR-O classification system are equally important for risk of chronic pancreatitis, at the level of the individual patient and in the general population. 108,438 women and men aged 20–100 years participating in the Copenhagen General Population Study from 2003 to 2015 were included. Associations of smoking, alcohol intake, waist/hip ratio, kidney function, plasma triglycerides, plasma Ca2+, and diseases within the causal pathway with risk of chronic pancreatitis, and corresponding population attributable risks were estimated. Information on chronic pancreatitis was from national Danish health registries. During median 9 years (range: 0–15) of follow-up, 313 individuals had a first diagnosis of chronic pancreatitis; the incidence of chronic pancreatitis per 10,000 person-years were 3.1 overall, 2.8 in women, and 3.5 in men. Of the six toxic risk factors and relative to individuals with low values, individuals in the top 5% had hazard ratios for chronic pancreatitis of 3.1(95% CI 2.1–4.5) for pack-years smoked, 2.5(1.5–4.0) for alcohol intake, and 1.6(1.1–2.6) for plasma triglycerides. Corresponding values versus those without the baseline disease were 12.6 (7.9–20.2) for acute pancreatitis, 1.9 (1.2–2.8) for gallstone disease, and 1.9 (1.3–2.7) for diabetes mellitus. The highest population attributable fractions were for women (1) ever smoking (31%), (2) gallstone disease (5%), and (3) diabetes mellitus (4%), and for men (1) ever smoking (38%), (2) acute pancreatitis (7%)/high alcohol intake (7%), and (3) high plasma triglycerides (5%). Smoking is the most important risk factor for chronic pancreatitis in the general population.
This is a preview of subscription content, access via your institution.




Availability of data and material
Data and further analyses will be made available upon reasonable request to corresponding author. The Danish Data Protection Agency does not allow open access to our data.
Code availability
Coding will be made available upon reasonable request to corresponding author.
References
Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017;62(7):1745–50. https://doi.org/10.1007/s10620-017-4518-x.
Olesen SS, Juel J, Nielsen AK, Frøkjær JB, Wilder-Smith OH, Drewes AM. Pain severity reduces life quality in chronic pancreatitis: implications for design of future outcome trials. Pancreatol: Off J Int Assoc Pancreatol (IAP). 2014;14(6):497–502. https://doi.org/10.1016/j.pan.2014.09.009.
Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut. 2011;60(1):77–84. https://doi.org/10.1136/gut.2010.213835.
Hart PA, Conwell DL. Chronic pancreatitis: managing a difficult disease. Am J Gastroenterol. 2020;115(1):49–55. https://doi.org/10.14309/ajg.0000000000000421.
Miksch RC, D’Haese JG, Werner J. Surgical therapy of chronic alcoholic pancreatitis: a literature review of current options. Visc Med. 2020;36(3):191–7. https://doi.org/10.1159/000508174.
Bellin MD, Beilman GJ, Sutherland DE, et al. How durable is total pancreatectomy and intraportal islet cell transplantation for treatment of chronic pancreatitis? J Am Coll Surg. 2019;228(4):329–39. https://doi.org/10.1016/j.jamcollsurg.2018.12.019.
Rickels MR, Robertson RP. Pancreatic islet transplantation in humans: recent progress and future directions. Endocr Rev. 2019;40(2):631–68. https://doi.org/10.1210/er.2018-00154.
Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45–55. https://doi.org/10.1016/s2468-1253(16)30004-8.
Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: a review. JAMA. 2019;322(24):2422–34. https://doi.org/10.1001/jama.2019.19411.
Sankaran SJ, Xiao AY, Wu LM, Windsor JA, Forsmark CE, Petrov MS. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology. 2015;149(6):1490-1500.e1. https://doi.org/10.1053/j.gastro.2015.07.066.
Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatol: Off J Int Assoc Pancreatol (IAP). 2016;16(2):218–24. https://doi.org/10.1016/j.pan.2016.02.001.
Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120(3):682–707. https://doi.org/10.1053/gast.2001.22586.
Schneider A, Löhr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 2007;42(2):101–19. https://doi.org/10.1007/s00535-006-1945-4.
Whitcomb DC, Yadav D, Adam S, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatol: Off J Int Assoc Pancreatol (IAP) 2008;8(4–5): 520–31. https://doi.org/10.1159/000152001
Conwell DL, Banks PA, Sandhu BS, et al. Validation of demographics, etiology, and risk factors for chronic pancreatitis in the USA: a report of the North American Pancreas Study (NAPS) Group. Dig Dis Sci. 2017;62(8):2133–40. https://doi.org/10.1007/s10620-017-4621-z.
Dominguez-Munoz JE, Drewes AM, Lindkvist B, et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatol: Off J Int Assoc Pancreatol (IAP). 2018;18(8):847–54. https://doi.org/10.1016/j.pan.2018.09.016.
Gardner TB, Adler DG, Forsmark CE, Sauer BG, Taylor JR, Whitcomb DC. ACG clinical guideline: chronic pancreatitis. Off J Am College Gastroenterol ACG. 2020;115(3):322–39. https://doi.org/10.14306/ajg.0000000000000535.
Whitcomb DC. Pancreatitis: TIGAR-O Version 2 Risk/Etiology checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol. 2019;10(6):e00027. https://doi.org/10.14309/ctg.0000000000000027.
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):e285–350. https://doi.org/10.1016/j.jacc.2018.11.003.
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88. https://doi.org/10.1093/eurheartj/ehz455.
Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European atherosclerosis society and European federation of clinical chemistry and laboratory medicine. Eur Heart J. 2016;37(25):1944–58. https://doi.org/10.1093/eurheartj/ehw152.
Kirkegard J, Mortensen MR, Johannsen IR, Mortensen FV, Cronin-Fenton D. Positive predictive value of acute and chronic pancreatitis diagnoses in the Danish national patient registry: a validation study. Scand J Public Health. 2018. https://doi.org/10.1177/1403494818773535.
https://www.stata.com/manuals13/restatic.pdf. Accessed 08.05, 2022.
https://www.stata.com/manuals/rkdensity.pdf. Accessed 09.05, 2022.
Xue J, Zhao Q, Sharma V, et al. Aryl hydrocarbon receptor ligands in cigarette smoke induce production of interleukin-22 to promote pancreatic fibrosis in models of chronic pancreatitis. Gastroenterology. 2016;151(6):1206–17. https://doi.org/10.1053/j.gastro.2016.09.064.
Lee AT, Xu Z, Pothula SP, et al. Alcohol and cigarette smoke components activate human pancreatic stellate cells: implications for the progression of chronic pancreatitis. Alcohol Clin Exp Res. 2015;39(11):2123–33. https://doi.org/10.1111/acer.12882.
Wittel UA, Pandey KK, Andrianifahanana M, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol. 2006;101(1):148–59. https://doi.org/10.1111/j.1572-0241.2006.00405.x.
Apte MV, Pirola RC, Wilson JS. Mechanisms of alcoholic pancreatitis. J Gastroenterol Hepatol. 2010;25(12):1816–26. https://doi.org/10.1111/j.1440-1746.2010.06445.x.
Hansen SEJ, Madsen CM, Varbo A, Nordestgaard BRG. Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population. Clin Chem. 2018. https://doi.org/10.1373/clinchem.2018.294926.
Hansen SEJ, Madsen CM, Varbo A, Tybjærg-Hansen A, Nordestgaard BG. Genetic variants associated with increased plasma levels of triglycerides, via effects on the lipoprotein lipase pathway, increase risk of acute pancreatitis. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2020. https://doi.org/10.1016/j.cgh.2020.08.016.
Dominguez-Munoz JE, Malfertheiner P, Ditschuneit HH, et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol. 1991;10(3–4):261–7.
Richardson A, Park WG. Acute pancreatitis and diabetes mellitus: a review. Korean J Intern Med. 2021;36(1):15–24. https://doi.org/10.3904/kjim.2020.505.
Yuan S, Giovannucci EL, Larsson SC. Gallstone disease, diabetes, calcium, triglycerides, smoking and alcohol consumption and pancreatitis risk: mendelian randomization study. NPJ Genom Med. 2021;6(1):27. https://doi.org/10.1038/s41525-021-00189-6.
Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Tobacco smoking and the risk of pancreatitis: a systematic review and meta-analysis of prospective studies. Pancreatol : Off J Int Assoc Pancreatol (IAP). 2019;19(8):1009–22. https://doi.org/10.1016/j.pan.2019.09.004.
Tolstrup JS, Kristiansen L, Becker U, Grønbaek M. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med. 2009;169(6):603–9. https://doi.org/10.1001/archinternmed.2008.601.
Prizment AE, Jensen EH, Hopper AM, Virnig BA, Anderson KE. Risk factors for pancreatitis in older women: the Iowa women’s health study. Ann Epidemiol. 2015;25(7):544–8. https://doi.org/10.1016/j.annepidem.2014.12.010.
Setiawan VW, Pandol SJ, Porcel J, et al. Prospective study of alcohol drinking, smoking, and pancreatitis: the multiethnic cohort. Pancreas. 2016;45(6):819–25. https://doi.org/10.1097/mpa.0000000000000657.
Pang Y, Kartsonaki C, Turnbull I, et al. Metabolic and lifestyle risk factors for acute pancreatitis in Chinese adults: a prospective cohort study of 0.5 million people. PLoS Med. 2018;15(8):e1002618. https://doi.org/10.1371/journal.pmed.1002618.
Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–61. https://doi.org/10.1053/j.gastro.2013.01.068.
Coté GA, Yadav D, Slivka A, et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2011;9(3):266–73. https://doi.org/10.1016/j.cgh.2010.10.015.
Samokhvalov AV, Rehm J, Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine. 2015;2(12):1996–2002. https://doi.org/10.1016/j.ebiom.2015.11.023.
Alsamarrai A, Das SL, Windsor JA, Petrov MS. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2014;12(10):1635–44. https://doi.org/10.1016/j.cgh.2014.01.038.
Jeon CY, Whitcomb DC, Slivka A, et al. Lifetime drinking history of persons with chronic pancreatitis. Alcohol Alcohol. 2019;54(6):615–24. https://doi.org/10.1093/alcalc/agz072.
Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet (London, England). 2020;396(10249):499–512. https://doi.org/10.1016/s0140-6736(20)31318-0.
Acknowledgements
We would like to thank staff and participants from the Copenhagen General Population Study for their valuable contributions.
Funding
This work was funded by the Novo Nordisk Foundation, Denmark, the Independent Research Fund, Denmark, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark, and Chief Physician Johan Boserup and Lise Boserup’s Fund, Denmark. The Copenhagen General Population Study was supported by Herlev and Gentofte Hospital, Copenhagen University Hospital, the Danish Heart Foundation, the Danish Medical Research Council, and the Copenhagen County Foundation.
Author information
Authors and Affiliations
Contributions
SEJH, BGN, and AL had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analyses. Study concept and design: SEJH, BGN, and AL. Acquisition, analyses and interpretation of data: SEJH, BGN, and AL. Drafting of manuscript: SEJH. Critical revision of the manuscript for important intellectual content: BGN and AL. Statistical analyses: SEJH and AL. Study supervision: BGN and AL.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethics approval
The study was conducted in accordance with the Declaration of Helsinki and approved by local institutional reviews boards and Danish ethical committees (H-KF-01–144/01).
Consent to participate
Written informed consent was obtained from all individuals.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hansen, S.E.J., Nordestgaard, B.G. & Langsted, A. Smoking as the most important risk factor for chronic pancreatitis in the general population. Eur J Epidemiol 38, 95–107 (2023). https://doi.org/10.1007/s10654-022-00945-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-022-00945-7
Keywords
- Epidemiology
- Cohort study
- Pancreas
- Gastroenterology
- Prevention
- Smoking
- Pancreatitis